5 mins | 30 mins | Hourly | Daily | Weekly |
---|---|---|---|---|
BUY | BUY | BUY | BUY | SELL |
5 mins | 30 mins | Hourly | Daily | Weekly | |
---|---|---|---|---|---|
MA5 | 0.67▲ | 0.67▲ | 0.66▲ | 0.66▲ | 0.68▲ |
MA10 | 0.66▲ | 0.65▲ | 0.65▲ | 0.67▲ | 0.55▲ |
MA20 | 0.65▲ | 0.65▲ | 0.65▲ | 0.67▲ | 0.73▼ |
MA50 | 0.65▲ | 0.65▲ | 0.66▲ | 0.58▲ | 1.49▼ |
MA100 | 0.65▲ | 0.66▲ | 0.65▲ | 0.77▼ | 3.94▼ |
MA200 | 0.66▲ | 0.67▲ | 0.65▲ | 1.30▼ | 11.72▼ |
5 mins | 30 mins | Hourly | Daily | Weekly | |
---|---|---|---|---|---|
MACD | 0.004▲ | 0.005▲ | 0.004▲ | -0.003▼ | 0.074▲ |
RSI | 63.508▲ | 60.279▲ | 58.401▲ | 53.299▲ | 42.623▼ |
STOCH | 91.132▲ | 78.043 | 74.164 | 45.659 | 55.162 |
WILL %R | -7.559▲ | -6.434▲ | -6.434▲ | -38.571 | -51.644 |
CCI | 82.569 | 132.360▲ | 162.412▲ | 7.077 | 2.852 |
Wednesday, August 13, 2025 09:19 PM
Moleculin Biotech ( ($MBRX) ) has released its Q2 earnings. Here is a breakdown of the information Moleculin Biotech presented to its investors.
|
Wednesday, August 13, 2025 08:19 AM
GAAP EPS was $(0.49) for Q2 2025, missing analyst estimates by 22.3%. Moleculin Biotech (NASDAQ:MBRX), a clinical-stage pharmaceutical developer focused on oncology, released its second quarter 2025 ...
|
Wednesday, August 13, 2025 05:15 AM
Continues recruitment and opens US and EU sites for the Phase 2B/3 MIRACLE trial- 20+ additional clinical sites in Europe and the US expected to begin recruitment by the end of Q3 - Anticipated data ...
|
date | open | high | low | close | volume |
---|---|---|---|---|---|
15/08/25 | 0.66 | 0.6854 | 0.63 | 0.6825 | 763,813 |
14/08/25 | 0.67 | 0.6701 | 0.6211 | 0.6478 | 678,332 |
13/08/25 | 0.67 | 0.695 | 0.6435 | 0.6748 | 988,396 |
12/08/25 | 0.6244 | 0.6643 | 0.6244 | 0.6621 | 608,940 |
11/08/25 | 0.6444 | 0.6697 | 0.6208 | 0.622 | 915,240 |
08/08/25 | 0.673 | 0.6774 | 0.6569 | 0.6745 | 571,256 |
07/08/25 | 0.6322 | 0.6825 | 0.6322 | 0.6774 | 626,064 |
06/08/25 | 0.73 | 0.73 | 0.6324 | 0.6557 | 3,183,294 |
05/08/25 | 0.68 | 0.7101 | 0.6541 | 0.6845 | 826,325 |
04/08/25 | 0.6477 | 0.6985 | 0.6112 | 0.6858 | 1,602,578 |
|
|
||||
|
|
||||
|
|